Pneumococcal conjugate second or third-dose vaccines (PCVc) in Angola

Angola: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 54.0% in 2025. ◆ Volatile

Latest (2025)
54.0%
Change on year
down 3.6%
World rank
153rd
of 194 countries
All-time high
68.0%
in 2018
All-time low
0.0%
in 2008
Years of data
18
2008–2025

Pneumococcal conjugate second or third-dose vaccines (PCVc) in Angola, 2008–2025

02040602008201620252008: 02009: 02010: 02011: 02012: 02013: 92014: 432015: 572016: 582017: 602018: 682019: 642020: 652021: 482022: 392023: 582024: 562025: 54

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Angola is 54.0%, measured in 2025.

Compared with earlier readings it is down 3.6% on the previous year and down 5.3% over ten years.

Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Angola peaked at 68.0% in 2018 and was at its lowest, 0.0%, in 2008.

Angola ranks 153rd of 194 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Pneumococcal conjugate second or third-dose vaccines (PCVc) in Angola, year by year

Annual values for Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC) in Angola, 2008 to 2025.
Year Value Change
2008 0.0% —
2009 0.0% —
2010 0.0% —
2011 0.0% —
2012 0.0% —
2013 9.0% —
2014 43.0% +377.8%
2015 57.0% +32.6%
2016 58.0% +1.8%
2017 60.0% +3.4%
2018 68.0% +13.3%
2019 64.0% -5.9%
2020 65.0% +1.6%
2021 48.0% -26.2%
2022 39.0% -18.8%
2023 58.0% +48.7%
2024 56.0% -3.4%
2025 54.0% -3.6%

Angola compared with similar countries

  • Angola's 54.0% is below the median for lower middle income countries, which is 84.0%, 64% of the median. (47 countries reporting)
  • Angola's 54.0% is below the median for Sub-Saharan Africa, which is 82.5%, 65% of the median. (48 countries reporting)

Biggest year-on-year movements

Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Angola changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2014 +377.8% 9.0% 43.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.0% 0.0% 0.0% 2
2010s 35.9% 0.0% 68.0% 10
2020s 53.3% 39.0% 65.0% 6

Countries ranked near Angola

  1. 151 Madagascar 56.0% compare
  2. 152 Slovenia 55.0% compare
  3. 153 Iran 54.0% compare
  4. 155 Azerbaijan 52.0% compare
  5. 156 Kazakhstan 49.0% compare
  6. 156 Chad 49.0% compare

See the full ranking of 207 places →

More health data for Angola

All data for Angola →

Frequently asked questions

What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Angola?
Pneumococcal conjugate second or third-dose vaccines (pcvc) in Angola was 54.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Angola?
The highest recorded value was 68.0% in 2018.
What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Angola?
The lowest recorded value was 0.0% in 2008.
How does Angola rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Angola ranks 153rd out of 194 countries with data for 2025.
Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Angola?
Over the last ten years it is down 5.3%. The long-run trend across the full record is volatile.
Where does this Angola data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Pneumococcal conjugate second or third-dose vaccines (PCVc) in Angola. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 26 September 2026, from https://health.statizoid.com/stat/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/angola/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/angola/">Pneumococcal conjugate second or third-dose vaccines (PCVc) in Angola</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 3,723 data points, 2008–2025
Last refreshed